This study shows that tumor hypoxia silences the STING pathway, impairing immune response in cancer, and suggests targeting KDM1A to restore STING and enhance cancer therapy.
This study investigates novel breast cancer therapeutic targets using multi-omics data, showing potential new drug targets for ER+, HER2+, and TNBC subtypes, crucial for advancing treatment options.
This study investigates how socioeconomic and racial disparities impact access to immunotherapy for triple-negative breast cancer in the U.S., showing equitable access can improve outcomes for marginalized groups.
This study investigates the unique psychosocial and support challenges faced by Black/African American and Hispanic/Latine women with early onset cancers, highlighting the need for culturally tailored interventions to improve care and support.
Yale Medicine Magazine was originally established in the 1950s as the medical school's alumni bulletin. Its articles cover discoveries in biomedicine, clinical advances, new ways of training tomorrow’s doctors, and the evolution of medicine and health care.